Abivax SA
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Abivax SA and buy or sell other stocks, ETFs, and their options commission-free!About ABVX
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines.
CEOMarc M. P. de Garidel
CEOMarc M. P. de Garidel
Employees69
Employees69
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2013
Founded2013
Employees69
Employees69
ABVX Key Statistics
Market cap10.45B
Market cap10.45B
Price-Earnings ratio-41.52
Price-Earnings ratio-41.52
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$128.87
High today$128.87
Low today$125.07
Low today$125.07
Open price$129.25
Open price$129.25
Volume63.11K
Volume63.11K
52 Week high$138.49
52 Week high$138.49
52 Week low$4.77
52 Week low$4.77
Stock Snapshot
With a market cap of 10.45B, Abivax SA(ABVX) trades at $127.00. The stock has a price-to-earnings ratio of -41.52.
On 2025-12-15, Abivax SA(ABVX) stock moved within a range of $125.07 to $128.87. With shares now at $127.00, the stock is trading +1.5% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 63.11K, compared to an average daily volume of 2M.
The stock's 52-week range extends from a low of $4.77 to a high of $138.49.
The stock's 52-week range extends from a low of $4.77 to a high of $138.49.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%